CHFW insider filings

Consonance-HFW Acquisition Corp. — 17 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-05-19. Screen CHFW transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for CHFW between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Consonance-HFW Acquisition Corp.

FiledFormInsiderReported transactionsSource
2021-05-194/ASoffer Benny — DirectorGrant/award (A): 24,000 · Grant/award (A): 8,000 (derivative)EDGAR
2021-05-194/ASoffer Benny — DirectorGrant/award (A): 3,593,750 @ $0.01 · Disposition to issuer (D): 718,750 @ $0 · Disposition to issuer (D): 575,000 @ $0 · Sale (S): 30,000 @ $0.01 · Sale (S): 30,000 @ $0.01 · Sale (S): 30,000 @ $0.01 · +2 moreEDGAR
2021-05-194/ALivingston Kevin Harold — Chief Financial OfficerGrant/award (A): 24,000 · Grant/award (A): 8,000 (derivative)EDGAR
2021-05-194/ALivingston Kevin Harold — Chief Financial OfficerGrant/award (A): 3,593,750 @ $0.01 · Disposition to issuer (D): 718,750 @ $0 · Disposition to issuer (D): 575,000 @ $0 · Sale (S): 30,000 @ $0.01 · Sale (S): 30,000 @ $0.01 · Sale (S): 30,000 @ $0.01 · +2 moreEDGAR
2021-05-194/AConsonance Life Sciences — DirectorGrant/award (A): 3,593,750 @ $0.01 · Disposition to issuer (D): 718,750 @ $0 · Disposition to issuer (D): 575,000 @ $0 · Sale (S): 30,000 @ $0.01 · Sale (S): 30,000 @ $0.01 · Sale (S): 30,000 @ $0.01 · +2 moreEDGAR
2021-05-194/AConsonance Life Sciences — Director, 10% ownerGrant/award (A): 24,000 · Grant/award (A): 8,000 (derivative)EDGAR
2021-05-194/ABLUTT MITCHELL J MD — DirectorGrant/award (A): 24,000 · Grant/award (A): 8,000 (derivative)EDGAR
2021-05-194/ABLUTT MITCHELL J MD — DirectorGrant/award (A): 3,593,750 @ $0.01 · Disposition to issuer (D): 718,750 @ $0 · Disposition to issuer (D): 575,000 @ $0 · Sale (S): 30,000 @ $0.01 · Sale (S): 30,000 @ $0.01 · Sale (S): 30,000 @ $0.01 · +2 moreEDGAR
2020-12-044BLUTT MITCHELL J MD — Director, 10% owner
Consonance Capital Management LP — Director, 10% owner
Consonance Capital Opportunity Fund Management LP — Director, 10% owner
Consonance Capman GP, LLC — Director, 10% owner
Purchase (P): 500,000 · Purchase (P): 371,100 · Purchase (P): 128,900EDGAR
2020-12-034Soffer Benny — DirectorPurchase (P): 24,000 · Purchase (P): 8,000 (derivative)EDGAR
2020-12-034Livingston Kevin Harold — Chief Financial OfficerPurchase (P): 24,000 · Purchase (P): 8,000 (derivative)EDGAR
2020-12-034Consonance Life Sciences — 10% ownerPurchase (P): 24,000 · Purchase (P): 8,000 (derivative)EDGAR
2020-12-034BLUTT MITCHELL J MD — DirectorPurchase (P): 24,000 · Purchase (P): 8,000 (derivative)EDGAR
2020-11-254Livingston Kevin Harold — Chief Financial OfficerPurchase (P): 410,000 · Purchase (P): 136,667 (derivative)EDGAR
2020-11-254Soffer Benny — DirectorPurchase (P): 410,000 · Purchase (P): 136,667 (derivative)EDGAR
2020-11-254Consonance Life Sciences — 10% ownerPurchase (P): 410,000 · Purchase (P): 136,667 (derivative)EDGAR
2020-11-254BLUTT MITCHELL J MD — DirectorPurchase (P): 410,000 · Purchase (P): 136,667 (derivative)EDGAR

Recent 8-K events — Consonance-HFW Acquisition Corp.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-168-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-208-K2.02 — Results of Operations and Financial Condition
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-028-K8.01 — Other EventsEDGAR
2026-08-068-K2.02 — Results of Operations and Financial ConditionEDGAR
2026-05-148-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-238-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-11-078-K2.02 — Results of Operations and Financial Condition
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CHFW returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs